THC Archives - Page 11 of 11

Some, But Not Enough Data on Cannabis for Chronic Pain

June 10, 2019 Arthritis, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Future Medicine, Muscle Pain, Neuropathy, Pain, Science, THC

Overlaps in pharmacology for the treatment of chronic pain and mental health disorders

Select small trials have demonstrated cannabis to be more effective than other analgesics to treat chronic pain associated with certain conditions. However, the existing research lacks large-scale, controlled experiments relating medical cannabis use to pain management. Additionally, negative effects are documented with respect to cannabis use among adolescents and those suffering from compromised mental health. There is a need for further research on the topic.

View this review (yellow link) or download:

Overlaps in pharmacology for the treatment of chronic pain and mental health disorders Download

This paper is also stored here: http://bit.ly/2wtvpRY inside the CED Foundation Archive

To explore related information, click keywords:

Misleading Headlines of THC “overdose”

June 7, 2019 Adverse Effects, Cannabis, Cannabis News, News, Overdose, Stigma, THC

Misleading headlines make it seem like this woman may have died of THC overdose, however, we know that it would be nearly impossible to consume lethal amounts of THC, and the coroner clearly made vague, and incomplete assumptions. This, likely feeding into a comfortable, though quite false stigma around cannabis. http://bit.ly/31iwwlK

Video: Medical Marijuana: What Physicians Need to Know

June 6, 2019 Autoimmunity, Cancer, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Extraction, Flavonoids, Future Medicine, IBS, Insomnia, Multiple Sclerosis, Muscle Pain, Neuropathy, Science, Sleep, Terpenes, THC, Video

A video adaptation of “Medical Marijuana: What Physicians Need to Know”

Medical_Marijuana_What_Physicians_Need_to_Know Download

This paper is also stored here: (http://bit.ly/2KxqoAe) inside the CED Foundation Archive

To explore related information, click the keywords below:

Sativex Reduces MS-Related Spasticity

June 5, 2019 Cannabis Science, CBD, Multiple Sclerosis, Muscle Pain, Neuropathy, THC

Delta-9-Tetrahydrocannabidiol Oromucosal Spray (Sativex): A Review in Multiple Sclerosis-Related Spasticity

A debilitating symptom of multiple sclerosis (MS) is spasticity, the stiffness and involuntary spasms of muscles, often occurring in the legs. In a randomized study involving MS patients who have not experienced relief with any current anti-spasticity medication, Sativex, a THC/CBD oro-mucosal spray was administered. Patients receiving THC/CBD experienced significantly more spasticity relief than the placebo group. Sativex may hold substantial treatment potential for MS patients, as side effects are minimized, the spray allows for an adjustable dosage, and there is low potential for abuse.

While this pharmaceutical is proving to be effective, in related data, we also see a distinct advantage of non-pharmaceutical options, including cost, availability, and efficacy, although drastically higher variability and limited consistency in product.

http://bit.ly/2WwVoqA

Medical Cannabis: Vaping Over Other Delivery Options

June 4, 2019 Adolescents, Cannabis Education, CBD, THC

Medical cannabis users prefer vaping for fast, portable, discrete treatment

Previous research shows that medical cannabis users prefer vaporization, or vaping, as a means for drug administration. In a Brown University study, 25 consumers of medical cannabis were surveyed to further investigate this phenomenon. Participants largely preferred vaping over other forms of delivery. Patients cite increased cost efficiency, discrete use, more ease in transporting medication when traveling, and more immediate symptom relief as reasons for this preference. Based on these data, vaping may be a valuable drug delivery option for cannabis users seeking a discrete, portable, effective treatment vehicle. bit.ly/2W378N3

Cannabinoids, Terpenoids, and ALSO flavonoids

June 1, 2019 Anxiety, Cannabinoids, Cannabis Science, CBD, Cortisol, Flavonoids, Stress

I wonder if we should be spending as much time on flavonoids as we do on terpenes (including cannabinoids)?

There is little doubt that they play a powerful effect. Just as the minor cannabinoids tend to be overlooked by much of the general & scientific cultures… flavonoids are also largely passed-over.

This study, for example, indicates that some of the components of dark chocolate reduce the body’s production of the stress hormone, cortisol (not surprising to most who have every consumed chocolate, but… did you know that those components are also found all over nature, including inside cannabis?!)

I’ll start adding flavonoids to the list of info to start sharing!

http://bit.ly/2W6C0w8

A lawsuit filed against the Justice Department re: de-scheduling

June 1, 2019 Cannabis News, Law

A lawsuit was filed against the Justice Department alleging that keeping cannabis on the CSA posed serious health risks. Originally dismissed, an appeal was filed and it was decided to leave the case open to apply pressure to the DEA to de-schedule cannabis. Action could be taken soon http://bit.ly/30Yrue3

Why Some People Freak Out on Cannabis, and Others Don’t

June 1, 2019 Anxiety, CBD, Terpenes

Cannabis can be promote increased anxiety in some people. While the details are not fully understood yet, the synergistic functioning of multiple cannabis components, known as the entourage effect, is a reliable way to lessen the paranoia and anxiety that may stem from the consumption of THC. Cannabinoids and terpenes such as CBD, pinene, linalool and more have been shown to help. http://bit.ly/3102p2w